Trial Profile

A Phase II Trial of ProLindac and Paclitaxel Combination as Second Line-Treatment in Platinum Pretreated Patients with Advanced Ovarian Cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 28 Jan 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AP 5346 (Primary) ; Paclitaxel
Indications Ovarian cancer
Focus Therapeutic Use
Sponsors Access Pharmaceuticals

Most Recent Events

24 Jan 2015 Status changed from recruiting to completed, according to European Clinical Trials Database
28 Mar 2012 Planned number of patients changed from 25 to 28 and additional trial location (France) added as reported by European Clinical Trials Database.
03 Nov 2010 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com